Osteoporosis: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

EU-13 is a filter, not a ranking: it only narrows the list.

24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

No stopped trial with a stated reason in this view.

Trials whose registry record says individual participant data (IPD) will be shared.

• Romosozumab and Denosumab Combination Therapy for Osteoporosis

  NCT07909304· Massachusetts General Hospital· Source

• Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes

  NCT06745544· Aalborg University Hospital· Source

• Quanduzhong Capsules for Primary Osteoporosis

  NCT07895082· Shanghai University of Traditional Chinese Medicine· Source

• A Study to Test the Efficacy, Safety and Tolerability of Romosozumab Treatment in Postmenopausal Chinese Women With Osteoporosis

  NCT05067335· UCB Biopharma SRL· Source

• Validation of a Deep Learning Tool for Opportunistic Osteoporosis Screening Using Routine Non-Contrast CT Scans

  NCT07739628· Union Hospital, Tongji Medical College, Huazhong University of Science and Technology· Source

• Novel Combination Therapy for Osteoporosis in Men

  NCT03994172· VA Office of Research and Development· Source

• GLP-1R Actions on Muscle and the Skeleton

  NCT07154719· Pennington Biomedical Research Center· Source

• A Study of Romosozumab in People With Breast Cancer and Osteoporosis

  NCT07776613· Memorial Sloan Kettering Cancer Center· Source

• Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD

  NCT07772609· Sahlgrenska University Hospital· Source

• OSTEOMICS: Identifying Regulators of Bone Homeostasis

  NCT05732870· Relation Therapeutics· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 16
• Organoids 1
• Mendelian Randomization Analysis 89
• CRISPR-Cas Systems 1
• Gene Expression Profiling 60
• Sequence Analysis, RNA 5
• Whole Genome Sequencing 1
• Exome Sequencing 6
• Proteomics 22
• Metabolomics 25
• Mass Spectrometry 7
• Flow Cytometry 6
• Immunohistochemistry 10
• Xenograft Model Antitumor Assays 3
• Magnetic Resonance Imaging 72
• Machine Learning 79
• Deep Learning 38
• Cohort Studies 236
• Genome-Wide Association Study 81

• Integrative analysis reveals shared biomarkers and pathways in osteoporosis and rheumatoid arthritis using machine learning and single-cell sequencing.

  PLoS One, Nov 2026

• A predictive model for osteoporosis in frail elderly patients with cerebral infarction: an integrated analysis based on machine learning and care-sensitive indicators.

  Front Endocrinol (Lausanne), Oct 2026

• A Clinical Primer on Computer Vision.

  Calcif Tissue Int, Oct 2026

• A primary care-oriented framework for osteoporosis prediction: integrating multi-algorithm feature selection and machine learning model benchmarking.

  Front Endocrinol (Lausanne), Oct 2026

• Integrated transcriptomic, machine learning, and network pharmacology analyses reveal shared inflammatory biomarkers between intervertebral disc degeneration and osteoporosis.

  Front Immunol, Oct 2026

• CT Radiomics and Machine Learning for Three-Class Bone Density Classification: An Exploratory Comparison Across Lumbar Vertebral Levels.

  Tomography, Oct 2026

• Artificial Intelligence and Machine Learning for Outcome Prediction After Osteoporotic Hip Fracture: A Systematic Review and Meta-analysis of Prediction Model Performance.

  Curr Osteoporos Rep, Sept 2026

• Integrative multimodal framework combining undercarboxylated osteocalcin and medial prefrontal cortex morphometry for prediction of cognitive decline in osteoporosis: a machine learning study.

  Front Neurol, Sept 2026

• Explainable Plasma Proteomics-Based Machine Learning for Osteoporosis Diagnosis, Prognosis, and Protein Biomarker Discovery in the UK Biobank.

  FASEB J, Sept 2026

• Secondary fragility fractures after hip fracture surgery in four thousand, four hundred and eighteen older adults: risk factors and internal validation of an interpretable machine-learning model.

  Int Orthop, Sept 2026

See which targets of this disease your abstract mentions, and go to the people working on them.